BioPass Pharma
Targeting Drugs and Molecules into the Brain
StartupBioPass Pharma is a Petah Tikva-based startup in the Health Tech & Life Sciences sector, established in 2021. Targeting Drugs and Molecules into the Brain. BioPass Pharma was founded by Elka Touitou, Tal Ben Yehuda, Shlomi Zandberg, Shlomi Zandberg, Hiba Natsheh. The company has 1-10 employees. Core technologies: Materials & Substances, Nanomaterials.
The company follows a B2B business model. Product stage: R&D. The company holds 1 patent.
- StagePre-Funding
- ProductR&D
- ModelB2B
- Employees1-10
- HQPetah Tikva
- DistrictCenter District
- Last RoundUndisclosed
Elka TouitouHead of the Advisory Board
Tal Ben YehudaCEO
Shlomi ZandbergQA & RA Director- Shlomi ZandbergDirector of Quality Assurance & Regulatory Affairs (QA/RA)
Hiba Natsheh
What does BioPass Pharma do?
BioPass Pharma is developing a revolutionary formulation intended for the treatment of brain or CNS diseases utilizing its patented novel technology, which is designed to deliver molecules directly into the brain by bypassing the BBB. Its novel nasal formulation offers short onset of a non-invasive, painless, easily administered treatment, avoiding gastrointestinal and hepatic presystemic metabolism. BioPass Pharma has secured exclusive rights for this technology from the Hebrew University of Jerusalem.
Who founded BioPass Pharma?
BioPass Pharma was founded in 2021 by Elka Touitou (Head of the Advisory Board), Tal Ben Yehuda (CEO), Shlomi Zandberg (QA & RA Director), Shlomi Zandberg (Director of Quality Assurance & Regulatory Affairs (QA/RA)), Hiba Natsheh.
What sector is BioPass Pharma in?
BioPass Pharma operates in Health Tech & Life Sciences, Pharma & Medical Biotechnology, Drug Delivery, with core technologies in Materials & Substances, Nanomaterials. Target customers: Healthcare & Life Sciences, Life Sciences, Biotechnology, Healthcare, Patients.
Where is BioPass Pharma located?
BioPass Pharma is based in Petah Tikva, Israel, Center District.